Delivery Order SPE2DR25D6048-SPE2DR26FAQR6
- Not listed
- The Defense Logistics Agency awarded a $1,117.74 delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials (5 ml quantity) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded transaction under the company's existing contract vehicles with DLA. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,930.96 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,069.28 to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,415.12 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials valued at $1,122.52. This competitively awarded, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.64 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on a firm fixed price basis. The contract, awarded December 8, 2025, with completion targeted for December 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,778.44 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dexamethasone 20 mg/5 mL vials (5 mL quantity). This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,563.00 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for a critical corticosteroid medication used across military and federal healthcare systems. The contract will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DR25D6048Indefinite Delivery Contract
- SPE2DR25D6048-SPE2DR26FAQR6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,568.18 to Amerisourcebergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical products to federal healthcare systems. This delivery order is issued under Amerisourcebergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. Dexamethasone, a corticosteroid medication commonly used for inflammatory conditions and medical emergencies, represents a routine pharmaceutical supply requirement under this framework agreement serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/11/26 |